Immatics is a Germany-based clinical-stage biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.
Business Model:
Revenue: $39.4M
Employees: 201-500
Address: Paul-Ehrlich-Str. 15
City: Tuebingen
State: baden-württemberg
Zip: 72076
Country: DE
Immatics is a Germany-based clinical-stage biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/2/2020
Ticker Symbol:
IMTX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|